[1]
“Oral Vs Subcutaneous Erythropoietin in Prevention of Anemia of Prematurity ”, The Insight, vol. 4, no. 01, pp. 34–43, Nov. 2021, Accessed: Nov. 21, 2024. [Online]. Available: https://bdjournals.org/index.php/insight/article/view/96